EBPS

Gender-affirming healthcare in Aotearoa hit by drug shortage

+News

Gender-affirming healthcare in Aotearoa hit by drug shortage

Amy van der Loo

Amy van der Loo

Friday 23 October 2020, 01:51 PM
Rainbow youth health
Transgender women are disproportionately affected by the natioanl shortage of oestradiol patches

Amy van der Loo rounds up the clinical education content in the latest issue of New Zealand Doctor. Use the embedded links to go through to the relevant ELearning page

A nationwide shortage of oestradiol patches (Estradot 25µg and 50µg) may disproportionately affect the most vulnerable in our society, such as transge
Related Links
Oestradiol patches 25 and 50 mcg: Supply issue - Pharmac
from bit.ly

News archive

Asthma_reprint

Latest news

Promised Pharmac review to report back by year-end but won’t touch funding issue

02/03/2021

Research register catches people up with everything health-IT related

02/03/2021

Pegasus boss takes six months out for South Island vaccination rollout

02/03/2021

Flu programme “definitely” going ahead on time

01/03/2021

Social media attack sees kids pulled out of rheumatic fever programme

01/03/2021

Pharmacy school enrolments plummet, heads admit it’s a struggle

01/03/2021

Waikato’s pan Pacific hub to turn traditional model of care on its head

26/02/2021

Hosted content

Galvus and Galvumet image

GALVUS® and GALVUMET® STILL FULLY FUNDED

GALVUS and GALVUMET remain an effective, subsidised treatment strategy for your type 2 diabetes patient not reaching their HbA1c target1-3 

Read more
Novartis New Zealand
Wednesday 10 February 2021, 01:27 PM

Latest issue

NZD COVER 170221

17 February 2021

View all issues

Facebook

New Zealand Doctor

Twitter